Insight Pharma Reports Offers Business Strategy Intelligence Reports for Life Sciences

March 25, 2011 - PRLog -- NEEDHAM, MASS. –  Cambridge Healthtech Institute’s Insight Pharma Reports offers five Business Strategy Intelligence Reports for Life Sciences.

•   Strategic Alliances: Synergistic Path to Value Creation – Author by Barry Davidson
•   Animal Models for Therapeutic Strategies – Author by Allan B. Haberman, Ph.D.
•   Outsourcing Preclinical Studies to China: Benefits and Challenges – Author by Eric Meyers, MBA
•   Direct to Consumer Genetic Testing: Business Prospects in the United States – Authored Kathie L. Wrick, PhD
•   Strategic Management of Resources and Portfolios – Author by Hermann A.M. Mucke, PhD

For more information and to purchase, visit: www.InsightPharmaReports.com

About Insight Pharma Reports (www.insightpharmareports.com)
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  www.InsightPharmaReports.com

# # #

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.